Delivery Order SPE2DB20D1100-SPE2DB24FD9N2

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $41K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HARVONI 90-400 MG 28S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $96,940.02, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 11, 2016. There was no set-aside designation for this award. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Harvoni, a prescription medication used to treat hepatitis C, in the amount of $88,212.12. The order has a firm fixed price and is set to be completed by September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,232.50 firm fixed-price delivery order (#SPE2DB22D6029|SPE2DB25FLTUU) is for the supply of MAVYRET 100-40 MG TABLET 84S, a medication used to treat chronic hepatitis C. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp's Corporate Office division. The $21,147.99 firm-fixed-price delivery order is for the supply of 4,565,091 units of the prescription medication Vemlidy 25 mg tablets. The contract has a period of performance through July 9, 2024. AmerisourceBergen, one of the largest pharmaceutical distribution companies globally, holds a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, valued at $16,741.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of Sofosbuvir-Velpatasvir 400-100 28S, a specialty pharmaceutical product. The contract does not include any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,193.06 fixed-price delivery order is for the supply of Vemlidy 25 mg tablets, a medication used to treat hepatitis B. The contract has a completion date of September 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,232.50 firm fixed-price delivery order is for the supply of 4,568,173,815 units of the prescription medication MAVYRET 100-40 MG TABLET 84S. The contract has a performance period through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order under a multi-year Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,596.53 delivery order is for Vemlidy 25 mg tablets, a treatment for chronic hepatitis B. The IDC, valued at $999,999,999, enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award, valued at $57,920.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award covers the...
This federal contract award, valued at $10,052.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Vemlidy 25 mg Tablet, with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD9N2
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $41,003.53 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565891282 HARVONI 90-400 MG TABLET UU 28S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities from AmerisourceBergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by September 23, 2024.

Generated 12/20/24, 9:34 AM